Accretion Pharmaceuticals launched its IPO on May 14, aiming to raise Rs 29.75 crore through a fresh issue of shares, with the IPO closing on May 16. The Gujarat-based company, which manufactures a range of healthcare products, plans to use the funds for capital expenditure, debt repayment, and working capital.
Dipan Mehta highlights capital goods and power as next market leaders
Dipan Mehta of Elixir Equities expresses disappointment in the banking sector’s recent performance, citing increased competition hindering growth. Excluding PSU banks, many NBFCs and private
August 13, 2025